Profound Infantile Neuroretinal Dysfunction in a Heterozygote for the CLN3 Genetic Defect

The neuronal ceroid-lipofuscinoses are a group of diseases that are characterized by progressive neuroretinal symptomatology, progressive accumulation of autofluorescing waxy lipopigments (ceroid-lipofuscin) within the brain and other tissues, and cerebral atrophy. Juvenile neuronal ceroid-lipofuscinosis, or Batten disease, is a form of neuronal ceroid-lipofuscinosis that is characterized by onset of neuroretinal symptoms between 4 and 10 years. Juvenile neuronal ceroid-lipofuscinosis is the most common type of neuronal ceroid-lipofuscinosis in the United States and Europe and is inherited as an autosomal recessive genetic disorder. Research in the last decade has led to the identification of the responsible gene for juvenile neuronal ceroid-lipofuscinosis, which is designated as CLN3. CLN3 is located on chromosome 16p11.2-12.1. The major mutation is a 1.02 kb deletion, which removes exons 7 and 8. Both homozygotic and heterozygotic deletions at the CLN3 gene site have been associated with the clinical syndromes of juvenile neuronal ceroid-lipofuscinosis. We report a possible atypical case of neuronal ceroid-lipofuscinosis, an infant, who presented at 5 months of age with a lack of developmental milestones, poor vision, severe retinopathy, intractable seizures, and progressive cerebral atrophy. Extensive laboratory investigations, including thorough metabolic evaluations, were unremarkable except for neuroimaging studies, electroencephalography, and electroretinography, all of which showed abnormalities confirming both cerebral and retinal degeneration. Although skin and conjunctival biopsies did not show classic fingerprint cytosomes by electron microscopic study, which characterize juvenile neuronal ceroid-lipofuscinosis, a diagnosis of an atypical form of juvenile neuronal ceroid-lipofuscinosis was suspected on the basis of the clinical picture. The retinal abnormalities, surprisingly, were those believed to be diagnostic of juvenile-onset neuronal ceroid-lipofuscinosis, or Batten disease. Subsequently, a heterozygous mutation for the common 1.02 kb deletion characteristic of juvenile neuronal ceroid-lipofuscinosis was established. (J Child Neurol 2004;19:42—46).

[1]  H. Goebel,et al.  The protracted form of juvenile neuronal ceroid-lipofuscinosis , 1976, Acta Neuropathologica.

[2]  K. Wisniewski,et al.  Pheno/genotypic correlations of neuronal ceroid lipofuscinoses , 2001, Neurology.

[3]  P. Taschner,et al.  New mutations in the neuronal ceroid lipofuscinosis genes. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[4]  G. Dawson,et al.  Batten's disease: Clues to neuronal protein catabolism in lysosomes , 2000, Journal of neuroscience research.

[5]  K. Wisniewski,et al.  Reevaluation of neuronal ceroid lipofuscinoses: atypical juvenile onset may be the result of CLN2 mutations. , 1999, Molecular genetics and metabolism.

[6]  N. Rawlings,et al.  Tripeptidyl-peptidase I is apparently the CLN2 protein absent in classical late-infantile neuronal ceroid lipofuscinosis. , 1999, Biochimica et biophysica acta.

[7]  P. Munroe,et al.  Delayed classic and protracted phenotypes of compound heterozygous juvenile neuronal ceroid lipofuscinosis , 1999, Neurology.

[8]  K. Wisniewski,et al.  Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S. , 1998, The Journal of clinical investigation.

[9]  T. Lerner,et al.  Spectrum of mutations in the Batten disease gene, CLN3. , 1997, American journal of human genetics.

[10]  M. Brodsky,et al.  Pediatric Neuro-Ophthalmology , 1995, Springer New York.

[11]  J. Haines,et al.  Isolation of a novel gene underlying batten disease, CLN3 , 1995, Cell.

[12]  K. Wisniewski,et al.  Classification of the neuronal ceroid-lipofuscinoses: expansion of the atypical forms. , 1995, American journal of medical genetics.

[13]  C. Slaughter,et al.  Molecular cloning and expression of palmitoyl-protein thioesterase. , 1994, The Journal of biological chemistry.

[14]  H. Eiberg,et al.  Batten disease (Spielmeyer‐Sjogren disease) and haptoglobins (HP): indication of linkage and assignment to chr. 16 , 1989, Clinical genetics.

[15]  M. Johnson,et al.  Patterns of muscle fiber-type disproportion in hypotonic infants. , 1984, Archives of neurology.

[16]  J. Rapola,et al.  Infantile Type of So‐called Neuronal Ceroid‐lipofuscinosis , 1973, Journal of the neurological sciences.

[17]  H. B. Marsden,et al.  Neuronal Ceroid Lipofuscinosis (Batten's Disease) , 1972, Archives of disease in childhood.

[18]  P. Dyken,et al.  Neuronal ceroid-lipofuscinosis (Batten's disease): relationship to amaurotic family idiocy? , 1969, Pediatrics.

[19]  N. Wood,et al.  A CONGENITAL FORM OF AMAUROTIC FAMILY IDIOCY , 1941, Journal of neurology and psychiatry.

[20]  F. Batten Cerebral degeneration, with symmetrical changes in the maculae, in two members of a family , 1903 .